Skip to main content

Advertisement

SpringerLink
Log in

Latest American and European Updates on Infantile Spasms

  • Pediatric Neurology (D Nordli, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Infantile spasms remain a challenging condition to study and treat, and although they form the commonest epilepsy syndrome with onset in infancy, the challenge is broadened by the wide range of potential underlying causes. The field of study remains dynamic, with debates relating to case definitions and organising structures for classification of seizures and epilepsies in general, and a newly proposed genetic and biologic classification specifically for infantile spasms. There have been recent consensus statements, a Delphi process eliciting prioritised quality-of-care indicators, systematic reviews of treatment, and a survey of clinical practice in the USA. There is increasing evidence that longer duration of spasms is associated with poorer neurodevelopmental outcomes. It has taken many years to develop an animal model that reasonably represents infantile spasms, but there are now several animal models, and they are leading to innovative and valuable studies that suggest novel treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51:676–85. This is a further initiative by the ILAE Commission on Classification and Terminology to develop concepts, definitions, clear terminology, and an overall classification and structure for the clinical management and design of studies for epilepsies.

    Article  PubMed  Google Scholar 

  2. Caraballo RH, Ruggieri V, Gonzalez G, Cersósimo R, Gamboni B, Rey A, et al. Infantile spasms without hypsarrhythmia: a study of 16 cases. Seizure. 2011;20:197–202.

    Article  PubMed  Google Scholar 

  3. •• Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol. 2011;45:355–67. This is a thorough and thoughtful review of genetic causes of infantile spasms, outlining how many of the newer genetic diagnoses are linked to key pathways of development in the central nervous system. This article also suggests models that might explain the pathogenesis of infantile spasms, with some emphasis on GABAergic gene regulation in the developing forebrain and abnormal expression of genes controlling synaptic molecules.

    Article  PubMed  Google Scholar 

  4. Adachi M, Abe Y, Aoki Y, Matsubara Y. Epilepsy in RAS/MAPK syndrome: two cases of cardio-facio-cutaneous syndrome with epileptic encephalopathy and a literature review. Seizure. 2012;21:55–60.

    Article  PubMed  Google Scholar 

  5. Mignot C, Moutard ML, Trouillard O, Gourfinkel-An I, Jacquette A, Arveiler B, et al. STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients. Epilepsia. 2011;52:1820–7.

    Article  PubMed  CAS  Google Scholar 

  6. Deprez L, Weckhuysen S, Holmgren P, Suls A, Van Dyck T, Goossens D, et al. Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations. Neurology. 2010;75:1159–65.

    Article  PubMed  CAS  Google Scholar 

  7. Mirzaa GM, Paciorkowski AR, Smyser CD, Willing MC, Lind AC, Dobyns WB. The microcephaly-capillary malformation syndrome. Am J Med Genet A. 2011;155A:2080–7.

    PubMed  Google Scholar 

  8. Striano P, Paravidino R, Sicca F, Chiurazzi P, Gimelli S, Coppola A, et al. West syndrome associated with 14q12 duplications harboring FOXG1. Neurology. 2011;76:1600–2.

    Article  PubMed  CAS  Google Scholar 

  9. Tohyama J, Yamamoto T, Hosoki K, Nagasaki K, Akasaka N, Ohashi T, et al. West syndrome associated with mosaic duplication of FOXG1 in a patient with maternal uniparental disomy of chromosome 14. Am J Med Genet A. 2011;155:2584–8.

    Article  CAS  Google Scholar 

  10. Bahi-Buisson N, Eisermann M, Nivot S, Bellanné-Chantelot C, Dulac O, Bach N, et al. Infantile spasms as an epileptic feature of DEND syndrome associated with an activating mutation in the potassium adenosine triphosphate (ATP) channel, Kir6.2. J Child Neurol. 2007;22(9):1147–50.

    Article  PubMed  Google Scholar 

  11. Coppola G, Grosso S, Verrotti A, D'Aniello A, Pascotto A. Simultaneous onset of infantile spasms in monozygotic twins. Pediatr Neurol. 2010;43:127–30.

    Article  PubMed  Google Scholar 

  12. •• Kamien BA, Cardamone M, Lawson JA, Sachdev R. A genetic diagnostic approach to infantile epileptic encephalopathies. J Clin Neurosci. 2012;19:934–41. This is a practical and user-friendly review of the causes of infantile seizures, many aspects of which are directly applicable to the management of infantile spasms. The framework, which it is suggested forms an effective and efficient triage for patients presenting with infantile spasms, is based on the organisation of concepts and terminology described in [1].

    Article  PubMed  Google Scholar 

  13. Gkampeta A, Pavlou E. Infantile spasms (West syndrome) in children with inborn errors of metabolism: a review of the literature. J Child Neurol. 2012;27:1295–301.

    Article  PubMed  Google Scholar 

  14. • Osborne JP, Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, et al. The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification. Epilepsia. 2010;51:2168–74. This study reports a representative sample of causes of infantile spasms, reminding us that many of the specific causes are sufficiently frequent to facilitate stratification or studies that might detect consistent interactions (effect-modification) between cause and treatment intervention.

    Article  PubMed  Google Scholar 

  15. Suleiman J, Brenner T, Gill D, Troedson C, Sinclair AJ, Brilot F, et al. Immune-mediated steroid-responsive epileptic spasms and epileptic encephalopathy associated with VGKC-complex antibodies. Dev Med Child Neurol. 2011;53:1058–60.

    Article  PubMed  Google Scholar 

  16. Stockler S, Plecko B, Gospe SM, Coulter-Mackie M, Connolly M, van Karnebeek C, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab. 2011;104:48–60.

    Article  PubMed  CAS  Google Scholar 

  17. Gallagher RC, Van Hove JL, Scharer G, Hyland K, Plecko B, Waters PJ, et al. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol. 2009;65:550–6.

    Article  PubMed  CAS  Google Scholar 

  18. • Autry AR, Trevathan E, Van Naarden Braun K, Yeargin-Allsopp M. Increased risk of death among children with Lennox-Gastaut syndrome and infantile spasms. J Child Neurol. 2010;25:441–7. This is an important follow-up on epidemiological outcomes from a cohort study in Atlanta.

    Article  PubMed  Google Scholar 

  19. Eisermann MM, DeLaRaillère A, Dellatolas G, Tozzi E, Nabbout R, Dulac O, et al. Infantile spasms in Down syndrome—effects of delayed anticonvulsive treatment. Epilepsy Res. 2003;55:21–7.

    Article  PubMed  CAS  Google Scholar 

  20. Kivity S, Lerman P, Ariel R, Danziger Y, Mimouni M, Shinnar S. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia. 2004;45:255–62.

    Article  PubMed  CAS  Google Scholar 

  21. O'Callaghan FJ, Lux AL, Darke K, Edwards SW, Hancock E, Johnson AL, et al. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study. Epilepsia. 2011;52:1359–64.

    Article  PubMed  Google Scholar 

  22. • Auvin S, Hartman AL, Desnous B, Moreau AC, Alberti C, Delanoe C, et al. Diagnosis delay in West syndrome: Misdiagnosis and consequences. Eur J Pediatr. 2012;171:1695–701. This is the most recent of a series of studies suggesting that diagnostic delay is likely to be associated with poorer neurodevelopmental outcomes, aggregately if not for all individuals. Unfortunately, diagnostic delay remains common, particularly where initial presentation is to a primary care physician rather than a paediatrician.

    Article  PubMed  Google Scholar 

  23. Napuri S, Le Gall E, Dulac O, Chaperon J, Riou F. Factors associated with treatment lag in infantile spasms. Dev Med Child Neurol. 2010;52:1164–6.

    Article  PubMed  Google Scholar 

  24. Partikian A, Mitchell WG. Neurodevelopmental and epilepsy outcomes in a North American cohort of patients with infantile spasms. J Child Neurol. 2010;25:423–8.

    Article  PubMed  Google Scholar 

  25. Vendrame M, Guilhoto LM, Loddenkemper T, Gregas M, Bourgeois BF, Kothare SV. Outcomes of epileptic spasms in patients aged less than 3 years: single-center United States experience. Pediatr Neurol. 2012;46:276–80.

    Article  PubMed  Google Scholar 

  26. • Mytinger JR, Joshi S. The current evaluation and treatment of infantile spasms among members of the Child Neurology Society. J Child Neurol. 2012;27:1289–94. Despite the relatively low response rate, this is a useful survey that indicates a broad range of approaches to the management of infantile spasms and demonstrates the need for clearer consensus.

    Article  PubMed  Google Scholar 

  27. •• Pellock JM, Hrachovy R, Shinnar S, Baram TZ, Bettis D, Dlugos DJ, et al. Infantile spasms: a U.S. consensus report. Epilepsia. 2010;51:2175–89. This presents a highly experienced group’s consensus on the management of infantile spasms with a basic outline of approaches to aetiologic investigation that is supplemented by [3, 12].

    Article  PubMed  Google Scholar 

  28. Dulac O, Bast T, Dalla Bernardina B, Gaily E, Neville B. Infantile spasms: toward a selective diagnostic and therapeutic approach. Epilepsia. 2010;51(10):2218–9. author reply 2221.

    Article  PubMed  Google Scholar 

  29. Statement of endorsement: Infantile spasms. Pediatrics 2012, 130:e1050.

  30. •• Go CY, Mackay MT, Weiss SK, Stephens D, Adams-Webber T, Ashwal S, et al. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2012;78:1974–80. This is an updated evidence-based guideline that is endorsed by influential professional bodies.

    Article  PubMed  CAS  Google Scholar 

  31. Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology. 2004;62:1668–81.

    Article  PubMed  CAS  Google Scholar 

  32. • Wang CJ, Jonas R, Fu CM, Ng CY, Douglass L. Quality-of-care indicators for infantile spasms. J Child Neurol. 2013;28(1):13–20. Given the paucity of high-class evidence for the optimal treatment of infantile spasms, this is an attempt to define pragmatic standards of care for infants with epileptic spasms.

    Article  PubMed  Google Scholar 

  33. • Appleton RE, Freeman A, Cross JH. Diagnosis and management of the epilepsies in children: A summary of the partial update of the 2012 NICE epilepsy guideline. Arch Dis Child 2012.

  34. • Arya R, Shinnar S, Glauser TA. Corticosteroids for the treatment of infantile spasms: a systematic review. J Child Neurol. 2012;27:1284–8. A systematic approach to reviewing the evidence on the relative efficacy of corticotropins and corticosteroids, and the relative efficacy of higher-dose and lower-dose regimens is presented.

    Article  PubMed  Google Scholar 

  35. Mytinger JR, Quigg M, Taft WC, Buck ML, Rust RS. Outcomes in treatment of infantile spasms with pulse methylprednisolone. J Child Neurol. 2010;25:948–53.

    Article  PubMed  Google Scholar 

  36. Ben-Menachem E. Mechanism of action of vigabatrin: correcting misperceptions. Acta Neurol Scand. 2011;124(Suppl192):5–15.

    Article  Google Scholar 

  37. Lerner JT, Salamon N, Sankar R. Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms. Neuropsychiatr Dis Treat. 2010;6:731–40.

    PubMed  CAS  Google Scholar 

  38. Heim MK, Gidal BE. Vigabatrin-associated retinal damage: potential biochemical mechanisms. Acta Neurol Scand. 2012;126:219–28.

    Article  PubMed  CAS  Google Scholar 

  39. Good WV. Measuring field loss in children administered vigabatrin: a problem in search of a solution. J AAPOS. 2011;15:411–2.

    Article  PubMed  Google Scholar 

  40. •• Sergott RC, Wheless JW, Smith MC, Westall CA, Kardon RH, Arnold A, et al. Evidence-based review of recommendations for visual function testing in patients treated with vigabatrin. Neuroophthalmology. 2010;34:20–35.

    Article  Google Scholar 

  41. McCoy B, Wright T, Weiss S, Go C, Westall CA. Electroretinogram changes in a pediatric population with epilepsy: is vigabatrin acting alone? J Child Neurol. 2011;26:729–33.

    Article  PubMed  Google Scholar 

  42. • Jammoul F, Dégardin J, Pain D, Gondouin P, Simonutti M, Dubus E, et al. Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats. Mol Cell Neurosci. 2010;43:414–21. Evidence from animal studies is presented that suggests a potential role of taurine in potentiating or ameliorating risks of visual field losses in association with vigabatrin.

    Article  PubMed  CAS  Google Scholar 

  43. Froger N, Cadetti L, Lorach H, Martins J, Bemelmans AP, Dubus E, et al. Taurine provides neuroprotection against retinal ganglion cell degeneration. PLoS One. 2012;7:e42017.

    Article  PubMed  CAS  Google Scholar 

  44. • Plant GT, Sergott RC. Understanding and interpreting vision safety issues with vigabatrin therapy. Acta Neurol Scand. 2011;124(Suppl192):57–71.

    Article  Google Scholar 

  45. Pearl PL, Vezina LG, Saneto RP, McCarter R, Molloy-Wells E, Heffron A, et al. Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia. 2009;50(2):184–94.

    Article  PubMed  CAS  Google Scholar 

  46. •• Pellock JM, Faught E, Sergott RC, Shields WD, Burkhart GA, Krauss GL, et al. Registry initiated to characterize vision loss associated with vigabatrin therapy. Epilepsy Behav. 2011;22:710–7. This describes an important initiative designed to provide reliable data to inform benefit–risk analyses for treatment with vigabatrin.

    Article  PubMed  Google Scholar 

  47. Hong AM, Turner Z, Hamdy RF, Kossoff EH. Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia. 2010;51:1403–7.

    Article  PubMed  Google Scholar 

  48. Numis AL, Yellen MB, Chu-Shore CJ, Pfeifer HH, Thiele EA. The relationship of ketosis and growth to the efficacy of the ketogenic diet in infantile spasms. Epilepsy Res. 2011;96:172–5.

    Article  PubMed  CAS  Google Scholar 

  49. • Lux AL, Osborne JP. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia. 2004;45:1416–28. A consensus is established on case definitions and preferred outcome measures for clinical studies of infantile spasms, on the basis of a Delphi process involving 30 participants from 15 countries.

    Article  PubMed  Google Scholar 

  50. Olson HE, Loddenkemper T, Vendrame M, Poduri A, Takeoka M, Bergin AM, et al. Rufinamide for the treatment of epileptic spasms. Epilepsy Behav. 2011;20:344–8.

    Article  PubMed  CAS  Google Scholar 

  51. Chhun S, Troude P, Villeneuve N, Soufflet C, Napuri S, Motte J, et al. A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target. Seizure. 2011;20:320–5.

    Article  PubMed  CAS  Google Scholar 

  52. Veerapandiyan A, Singh P, Mikati MA. Possible induction of West syndrome by oxcarbazepine therapy in a patient with complex partial seizures. Epileptic Disord. 2012;14:99–103.

    PubMed  Google Scholar 

  53. Chugani HT, Asano E, Sood S. Infantile spasms: who are the ideal surgical candidates? Epilepsia. 2010;51(Suppl1):94–6.

    Article  PubMed  Google Scholar 

  54. • Stafstrom CE. Infantile spasms: a critical review of emerging animal models. Epilepsy Curr. 2009;9:75–81. This is a brief review of animal models with a critical appraisal of the attributes required for a valid and useful model.

    Article  PubMed  Google Scholar 

  55. Velísek L, Chachua T, Yum MS, Poon KL, Velísková J. Model of cryptogenic infantile spasms after prenatal corticosteroid priming. Epilepsia. 2010;51(Suppl3):145–9.

    Article  PubMed  Google Scholar 

  56. Chachua T, Yum MS, Velíšková J, Velíšek L. Validation of the rat model of cryptogenic infantile spasms. Epilepsia. 2011;52:1666–77.

    Article  PubMed  CAS  Google Scholar 

  57. Frost JD, Lee CL, Hrachovy RA, Swann JW. High frequency EEG activity associated with ictal events in an animal model of infantile spasms. Epilepsia. 2011;52:53–62.

    Article  PubMed  Google Scholar 

  58. Cortez MA, Shen L, Wu Y, Aleem IS, Trepanier CH, Sadeghnia HR, et al. Infantile spasms and Down syndrome: a new animal model. Pediatr Res. 2009;65:499–503.

    Article  PubMed  Google Scholar 

  59. Chudomelova L, Scantlebury MH, Raffo E, Coppola A, Betancourth D, Galanopoulou AS. Modeling new therapies for infantile spasms. Epilepsia. 2010;51(Suppl3):27–33.

    Article  PubMed  CAS  Google Scholar 

  60. Scantlebury MH, Galanopoulou AS, Chudomelova L, Raffo E, Betancourth D, Moshé SL. A model of symptomatic infantile spasms syndrome. Neurobiol Dis. 2010;37:604–12.

    Article  PubMed  Google Scholar 

  61. • Raffo E, Coppola A, Ono T, Briggs SW, Galanopoulou AS. A pulse rapamycin therapy for infantile spasms and associated cognitive decline. Neurobiol Dis. 2011;43:322–9. Using one of the new animal models to investigate whether a biologically plausible but innovative approach to treatment has sufficient empirical support to merit further investigation and potential application to treatment in humans.

    Article  PubMed  CAS  Google Scholar 

  62. Fat MJ, Doja A, Barrowman N, Sell E. YouTube videos as a teaching tool and patient resource for infantile spasms. J Child Neurol. 2011;26:804–9.

    Article  PubMed  Google Scholar 

  63. Jobst BC. Infantile spasms: the devil is in the details, but do we see the forest for the trees? Epilepsy Curr. 2011;11:151–2.

    Article  PubMed  Google Scholar 

  64. Mohamed BP, Scott RC, Desai N, Gutta P, Patil S. Seizure outcome in infantile spasms—a retrospective study. Epilepsia. 2011;52:746–52.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Paediatric Neurology, Bristol Royal Hospital for Children, Floor 6, UHBristol Education Centre, Upper Maudlin Street, Bristol, BS2 8AE, UK

    Andrew L. Lux

Authors
  1. Andrew L. Lux
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew L. Lux.

Additional information

This article is part of the Topical Collection on Pediatric Neurology

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lux, A.L. Latest American and European Updates on Infantile Spasms. Curr Neurol Neurosci Rep 13, 334 (2013). https://doi.org/10.1007/s11910-012-0334-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11910-012-0334-z

Keywords

Search

Navigation